OptimizeRx Corp
OptimizeRx Corporation (OPRX) operates a digital health platform that connects pharmaceutical manufacturers, healthcare providers, and patients through targeted digital communications and data analytics. The company's website is www.optimizerx.com. From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What OptimizeRx Corp does
In the company’s own words
OptimizeRx Corporation (OPRX) operates a digital health platform that connects pharmaceutical manufacturers, healthcare providers, and patients through targeted digital communications and data analytics. The company's website is www.optimizerx.com.
The company operates primarily through its core digital health communications business, which leverages proprietary algorithms and data analytics to identify trends and enable personalized digital outreach to patients and healthcare providers. OptimizeRx's platform facilitates connections between pharmaceutical companies seeking to promote their products and patients who may benefit from those medications, while also providing healthcare providers with relevant clinical information and patient support resources.
The business model centers on channel partnerships and data provider relationships that enable digital connectivity to patients and doctors. These partnerships provide OptimizeRx with access to communication channels and data insights necessary to deliver targeted, relevant messaging at scale. The company's revenue is generated primarily through fees paid by pharmaceutical manufacturers for access to the platform and the ability to reach specific patient and provider audiences.
OptimizeRx's competitive advantages include its proprietary algorithms for identifying patient populations, its established relationships with channel partners and data providers, and its integrated platform that streamlines the process of connecting pharmaceutical companies with their target audiences. The company operates in the digital health and pharmaceutical marketing technology sector, which has experienced significant growth as pharmaceutical companies increasingly shift marketing budgets toward digital channels and data-driven targeting.
The company expanded its capabilities through the acquisition of Healthy Offers, Inc., which was consummated on the closing date of the financing agreement referenced in this document. This acquisition, funded through a $40 million term loan facility provided by Blue Torch Finance, LLC and related lenders, represents a strategic expansion of OptimizeRx's digital health platform and service offerings to pharmaceutical manufacturers and healthcare stakeholders.
Company details
- Sector
- Industrials
- Industry
- Business Services
- Headquarters
- WALTHAM, MA
- Fiscal year end
- December
- CIK
- 1448431
- SIC
- 7389
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns OptimizeRx Corp — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · OptimizeRx Corp’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do OptimizeRx Corp and its peers compare on margins and cash generation over ten years?”
- “Where did five years of OptimizeRx Corp's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in OptimizeRx Corp's last four quarterly filings that the numbers alone won't show?”
